* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, July 24, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Black Box Players presents ‘The Three Musketeers’ – CBS 19 News

    Experience the Adventure: Black Box Players Bring ‘The Three Musketeers’ to Life!

    AP Entertainment SummaryBrief at 1:51 p.m. EDT – Channel 3000

    Entertainment Highlights: Key Updates You Can’t Miss

    ‘Devil Wears Prada 2’ casts Anne Hathaway’s love interest replacing Adrian Grenier’s Nate – Entertainment Weekly

    Devil Wears Prada 2′ Casts New Love Interest for Anne Hathaway, Replacing Adrian Grenier’s Nate

    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Sustainserv and Palau Announce Technology Partnership to Leverage Innovative AI Platform to Advance Sustainability Reporting – Business Wire

    Sustainserv and Palau Team Up to Transform Sustainability Reporting with Breakthrough AI Technology

    Morgan Adamski Joins PwC in Newly Created Cyber, Data & Technology Risk Division – HSToday

    Morgan Adamski Leads the Charge in PwC’s Cutting-Edge Cyber, Data & Technology Risk Division

    Transformative technology, support for food entrepreneurs spotlighted – University of Hawaii System

    How Cutting-Edge Technology and Strong Support Are Revolutionizing Food Entrepreneurs’ Success

    Cold Weather Alloy Opens New Possibilities for Space Technology – Universe Today

    Revolutionary Cold Weather Alloy Unlocks New Frontiers in Space Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Black Box Players presents ‘The Three Musketeers’ – CBS 19 News

    Experience the Adventure: Black Box Players Bring ‘The Three Musketeers’ to Life!

    AP Entertainment SummaryBrief at 1:51 p.m. EDT – Channel 3000

    Entertainment Highlights: Key Updates You Can’t Miss

    ‘Devil Wears Prada 2’ casts Anne Hathaway’s love interest replacing Adrian Grenier’s Nate – Entertainment Weekly

    Devil Wears Prada 2′ Casts New Love Interest for Anne Hathaway, Replacing Adrian Grenier’s Nate

    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Sustainserv and Palau Announce Technology Partnership to Leverage Innovative AI Platform to Advance Sustainability Reporting – Business Wire

    Sustainserv and Palau Team Up to Transform Sustainability Reporting with Breakthrough AI Technology

    Morgan Adamski Joins PwC in Newly Created Cyber, Data & Technology Risk Division – HSToday

    Morgan Adamski Leads the Charge in PwC’s Cutting-Edge Cyber, Data & Technology Risk Division

    Transformative technology, support for food entrepreneurs spotlighted – University of Hawaii System

    How Cutting-Edge Technology and Strong Support Are Revolutionizing Food Entrepreneurs’ Success

    Cold Weather Alloy Opens New Possibilities for Space Technology – Universe Today

    Revolutionary Cold Weather Alloy Unlocks New Frontiers in Space Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Business

MiDROPS® Achieves Pivotal Milestone: Proven Safe and Effective in Phase II Clinical Trial

May 7, 2024
in Business
MiDROPS® Achieves Pivotal Milestone: Proven Safe and Effective in Phase II Clinical Trial
Share on FacebookShare on Twitter

Author of the article:

Business Wire

Published May 07, 2024  •  3 minute read

OKLAHOMA CITY — EyeCRO is thrilled to announce that groundbreaking data from the first clinical application of its innovative MiDROPS® platform technology is being presented by Telios Pharma at the 96th meeting of the Association for Research in Vision and Ophthalmology meeting in Seattle, WA. The presentation entitled, “TL-925, a First-in-Class, Topical, Bruton’s Tyrosine Kinase Inhibitor in Subjects with Moderate to Severe Dry Eye Disease” (Poster 2965 – A0124), demonstrated MiDROPS® exceptional capability to safely formulate and deliver lipophilic molecules via topical eyedrops, showcasing the technology’s significant potential in revolutionizing eye care.

Advertisement 2

This advertisement has not loaded yet, but your article continues below.

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

Exclusive articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman, Victoria Wells and others.Daily content from Financial Times, the world’s leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

Exclusive articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman, Victoria Wells and others.Daily content from Financial Times, the world’s leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.

Sign In or Create an Account

or

Article content

This proof-of-concept phase 2 study evaluated the effect of 0.1% TL-925 vs Vehicle, dosed twice daily, in 107 patients with moderate to severe dry eye disease (DED) over 28 days. Both TL-925 and the MiDROPS® vehicle were safe and well-tolerated. Mean drop comfort score was 2.6 (scale: 0-10) in both the treatment and vehicle Study Eye with the most common treatment-emergent adverse event of low-grade (grade 1) instillation site irritation. These results demonstrate the impressive safety and tolerability profile of MiDROPS®. Importantly, this is the first clinical study to establish the critical role of Bruton’s tyrosine kinase (BTK) in the pathophysiology of DED. Specifically, TL-925 demonstrated clinically meaningful and statistically significant efficacy (intention-to-treat, N=107) across multiple signs of DED, including Central and Total Corneal Fluorescein Staining (p=0.01 and p=0.034, respectively) and symptoms of DED, Visual Analog Scale – pain, OD4SQ – dryness and burning (p=0.014, p=0.026, and p=0.034, respectively).

Article content

Setting a new standard in eye care, MiDROPS® utilizes a unique approach with its single-phase microemulsions which incorporate surfactant levels surpassing those previously explored in ophthalmic treatments. “We are elated to establish this important clinical proof-of concept for MiDROPS® as an eyedrop vehicle. The data fundamentally demonstrate that these ordered formulations can be safely applied and confer therapeutic activity. We are excited for the potential of this platform technology to revolutionize the way ophthalmic drugs are formulated and delivered via eyedrops to tissues of both the anterior and posterior segment,” said Dr. Rafal Farjo, Chief Executive Officer of EyeCRO.

Echoing this sentiment, Dr. Jesse McGreivy, CEO of Telios Pharma, highlighted the strategic benefits of this collaboration, “The inherent nature of MiDROPS® allowed us to easily formulate TL-925 and accelerate advancement into clinical trials. The clinical data presented today both establishes the safety of this novel vehicle platform and showcases the potentially paradigm-changing role of BTK inhibition to alleviate the signs and symptoms of patients with moderate to severe DED.”

About MiDROPS®

MiDROPS® (Microemulsion Drug Ocular Penetration System) is a revolutionary platform technology which employs cutting-edge microemulsions to formulate and deliver lipophilic and insoluble drugs via topical eyedrops. This innovative approach allows for the effective treatment of eye diseases by facilitating drug delivery directly into tissues of both the anterior and posterior segments of the eye, a feat not possible with traditional ophthalmic formulations. This broad library of single-phase microemulsions represents a breakthrough in ophthalmic drug delivery, offering enhanced bioavailability, greater therapeutic efficacy, and improved patient compliance. MiDROPS® is protected by patents globally, ensuring its unique formulations remain exclusive to EyeCRO, which it makes available on a licensing basis to interested parties. For more information, visit MiDROPS.com.

Advertisement 3

This advertisement has not loaded yet, but your article continues below.

Article content

About EyeCRO

EyeCRO is at the forefront of ophthalmic research, recognized as a leading Contract Research Organization dedicated to advancing the frontiers of vision research and new therapeutic development. Their experienced scientific team provides a wide range of services, including preclinical pharmacology and eyedrop formulation development with MiDROPS®, tailored to support groundbreaking ophthalmic development programs. The company operates laboratories in Oklahoma City, OK and Ann Arbor, Michigan and extends its specialized services to partners worldwide. For more information, visit EyeCRO.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507085882/en/

logo

Contacts

[email protected]

Article content

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Financial Post – https://financialpost.com/pmn/business-wire-news-releases-pmn/midrops-achieves-pivotal-milestone-proven-safe-and-effective-in-phase-ii-clinical-trial

Tags: achievesbusinessMiDROPS®
Previous Post

Summer Gasoline Prices Seen Holding Steady in Relief for Drivers

Next Post

Klick Health Wraps First Round of $1,000,000 Klick AI Prize, Awarding First $200,000 to Three Teams

Join the Neighborhood Ecology Corps – RaleighNC.gov

Join the Neighborhood Ecology Corps – RaleighNC.gov

July 24, 2025

WEBS Program Ignites Passion for Science with Exciting Hands-On Labs

July 24, 2025

Science Explains Why Some People Keep Making Bad Decisions Even After Being Punished – Study Finds

July 24, 2025
Fidel Castro’s grandson slammed for flaunting lavish lifestyle amid Cuba’s economic crisis – Mint

Fidel Castro’s Grandson Stuns Nation with Lavish Lifestyle Amid Cuba’s Economic Struggles

July 23, 2025
Art on the Road: Framing the World – Oregon ArtsWatch

Art on the Road: Framing the World – Oregon ArtsWatch

July 23, 2025
Zimbabwe Says Informal Sector Dominates 76% of The Economy – Bloomberg

Zimbabwe’s Informal Sector Now Powers 76% of the Economy

July 23, 2025
MSC Cruises Unveils Entertainment Venues Aboard New Ship MSC World Asia – TravelPulse

Explore the Thrilling New Entertainment Venues Aboard MSC World Asia!

July 23, 2025
Mitochondria and health – National Institutes of Health (NIH) | (.gov)

Unlocking the Power of Mitochondria: The Key to Better Health

July 23, 2025
Trump’s latest bid to end Epstein storm: Weaponizing the federal government – CNN

Trump’s Bold New Move to Turn the Federal Government Against the Epstein Controversy

July 23, 2025
Sustainserv and Palau Announce Technology Partnership to Leverage Innovative AI Platform to Advance Sustainability Reporting – Business Wire

Sustainserv and Palau Team Up to Transform Sustainability Reporting with Breakthrough AI Technology

July 23, 2025

Categories

Archives

July 2025
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Jun    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (736)
  • Economy (759)
  • Entertainment (21,642)
  • General (16,067)
  • Health (9,797)
  • Lifestyle (767)
  • News (22,149)
  • People (761)
  • Politics (768)
  • Science (15,975)
  • Sports (21,256)
  • Technology (15,741)
  • World (742)

Recent News

Join the Neighborhood Ecology Corps – RaleighNC.gov

Join the Neighborhood Ecology Corps – RaleighNC.gov

July 24, 2025

WEBS Program Ignites Passion for Science with Exciting Hands-On Labs

July 24, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version